| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/08/1996 | EP0710235A1 Endothelin antagonists |
| 05/08/1996 | EP0585440B1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 05/02/1996 | WO1996012797A1 Production and use of human and plant methyltransferases |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203265A1 Production and use of human and plant methyltransferases |
| 05/01/1996 | EP0709375A2 Therapeutic heterocycles |
| 05/01/1996 | EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| 05/01/1996 | EP0708657A1 Compositions for nasal administration of desmopressin |
| 05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 05/01/1996 | EP0708647A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 05/01/1996 | CN1121709A Oxytocin antagonist |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 04/30/1996 | US5512580 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation |
| 04/30/1996 | US5512563 Tricyclic benzazepine vasopressin antagonists |
| 04/30/1996 | US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site |
| 04/30/1996 | CA1338287C Hetrazepines and processes for preparing them |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996011914A1 New carboxylic acid derivatives, their preparation and their use |
| 04/25/1996 | WO1996011685A2 Use of indole derivatives for the treatment of various diseases |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/24/1996 | EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists |
| 04/24/1996 | EP0707850A1 Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain |
| 04/24/1996 | EP0707490A1 Neuropeptide y antagonists and agonists |
| 04/24/1996 | EP0450097B1 Benzoheterocyclic compounds |
| 04/24/1996 | CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them |
| 04/23/1996 | US5510386 Aminosulfonylphenyl compounds for treating urinary incontinence |
| 04/23/1996 | US5510345 Biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 04/23/1996 | US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | DE19533023A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use |
| 04/17/1996 | EP0706994A1 Melatonergic agents |
| 04/17/1996 | EP0706533A1 Synthetic peptides of human papillomavirus |
| 04/17/1996 | EP0706525A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 04/17/1996 | CN1120844A Phosphonomethyldipeptides |
| 04/17/1996 | CN1120838A Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 04/17/1996 | CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them |
| 04/17/1996 | CN1031574C Process for preparation of 4-amino-delta-4, 6-steroid(s) compounds |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/16/1996 | US5508419 Substituted triazoles as angiotensin II inhibitors |
| 04/16/1996 | US5508306 Used for treatment of benign prostatic hyperplasia, lowering intraocular pressure and inhibiting cholesterol synthesis |
| 04/16/1996 | US5508299 Angiotensin converting enzyme inhibitor, arterial hypotensive agent; cardiovascular disorders |
| 04/16/1996 | US5508284 Treating 5-hydroxytryptamine modulation |
| 04/16/1996 | US5508279 Increases urine flow while avoiding hypotensive effects |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/11/1996 | WO1996010416A1 DRUGS CONTAINING β-INTERFERON |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2199154A1 The use of medicaments containing interferon-beta |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0705266A1 Process for producing imidazole derivative |
| 04/10/1996 | EP0705244A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 04/10/1996 | EP0504254B1 The use of gibberellins for the manufacture of a medicament for the treatment of prostatitis |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/10/1996 | CN1120337A Process for production of an imidazole derivative |
| 04/09/1996 | US5506270 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| 04/09/1996 | US5506207 GNRH antagonists XIII |
| 04/09/1996 | CA1338238C Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009826A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | CA2200858A1 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704057A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 04/03/1996 | EP0703924A1 Biologically active vasopressin analogues |
| 04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
| 04/03/1996 | EP0703904A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 04/02/1996 | US5504089 Treating urinary incontinence |
| 04/02/1996 | US5504080 Benzo-fused lactams |
| 04/02/1996 | US5503843 Transdermal delivery of alpha adrenoceptor blocking agents |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/28/1996 | WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin |
| 03/28/1996 | WO1996009051A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
| 03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | CA2200205A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 03/28/1996 | CA2200204A1 Benzothiophene compounds, compositions, and methods |
| 03/27/1996 | EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome |
| 03/27/1996 | EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them |
| 03/27/1996 | EP0703221A1 5 alpha-reductase Inhibitors |
| 03/27/1996 | EP0702961A2 Compositions for minimizing the uterotrophic effect of tamoxifen and its analogs |
| 03/27/1996 | EP0702555A1 Pyrazolopyrimidinones for the treatment of impotence |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/27/1996 | CN1119434A Phenoxyphenylacetic acid derivatives |
| 03/27/1996 | CN1119189A New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them |
| 03/27/1996 | CN1031404C Process for production of substituted azole |
| 03/22/1996 | CA2158591A1 Fatty acid treatment |
| 03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | WO1996008557A1 Human inositol monophosphatase h1 |
| 03/21/1996 | WO1996008489A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 03/21/1996 | WO1996008463A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |